Related Experiment Video
Updated: Oct 19, 2025

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
Published on: September 28, 2018
Protein Kinase D3 Promotes the Reconstruction of OSCC Immune Escape Niche Via Regulating MHC-I and Immune Inhibit
Die Lv1, Jiao Chen, Yingzhu Kang
1State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan Province, People's Republic of China.
Abstract:
Protein kinase D3 (PKD3) has been involved in various aspects of tumorigenesis and progression in many kinds of cancer types. However, whether PKD3 regulates immune escape in tumor microenvironment is rarely reported. Here, we explored the function and mechanism of PKD3 in reconstructing the immune escape niche of oral squamous cell carcinoma (OSCC). Both the Western blotting analysis in OSCC cells and the gene expression correlation analysis from The Cancer Genome Atlas shows that the expression of Fas and programmed cell death-ligand 1 (PD-L1) was positively correlated with PKD3, while major histocompatibility complex-I (MHC-I) was negatively correlated with PKD3. Knockdown of PKD3 significantly decreased the expression of Fas and PD-L1 and increased the expression of MHC-I. Furthermore, when PKD3 was overexpressed in oral precancerous cells, Fas, PD-L1, and MHC-I showed an opposite trend to that observed when PKD3 was knocked down. In addition, PKD3 knockdown decreased the secretion of transforming growth factor β, CC-chemokine ligand 21, interleukin-10 by OSCC cells. Finally, the tumor cell antigen, which was extracted from PKD3 knockdown OSCC cells, significantly induced the growth and activation of T lymphocytes. These results demonstrate that PKD3 promotes the immune escape of OSCC cells by regulating the expression of Fas, PD-L1, MHC-I, transforming growth factor β, CC-chemokine ligand 21, interleukin-10, and plays a key role in reconstructing the tumor immune escape niche.
Insights
Protein kinase D3 (PKD3) promotes oral cancer immune escape by altering immune-related molecules like PD-L1 and MHC-I. This impacts the tumor microenvironment and T cell responses, highlighting PKD3 as a potential therapeutic target.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Protein kinase D3 (PKD3) is implicated in various cancers.
- Its role in tumor immune escape, particularly in oral squamous cell carcinoma (OSCC), is largely unexplored.
Purpose of the Study:
- To investigate the function and mechanism of PKD3 in shaping the immune escape niche of OSCC.
- To determine PKD3's impact on key immune regulatory molecules within the tumor microenvironment.
Main Methods:
- Western blotting analysis of OSCC cells.
- Gene expression correlation analysis using The Cancer Genome Atlas (TCGA) data.
- PKD3 knockdown and overexpression experiments in OSCC and precancerous cells.
- Measurement of cytokine secretion.
- T lymphocyte activation assays.
Main Results:
- PKD3 expression positively correlated with Fas and PD-L1, and negatively with MHC-I in OSCC.
- PKD3 knockdown decreased Fas and PD-L1, increased MHC-I, and reduced secretion of TGF-β, CCL21, and IL-10.
- PKD3 overexpression showed opposite effects.
- Tumor antigens from PKD3-knockdown cells enhanced T lymphocyte growth and activation.
Conclusions:
- PKD3 promotes OSCC immune escape by modulating Fas, PD-L1, MHC-I, TGF-β, CCL21, and IL-10.
- PKD3 plays a critical role in reconstructing the tumor immune escape niche.
- Targeting PKD3 may offer a strategy to overcome immune evasion in OSCC.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation

